LifeWallet Announces a $2 Million Pharmaceutical Litigation Settlement and Ongoing Settlement Negotiations with Multiple P&C Insurers, Pharmaceutical and Medical Device Manufacturers, While Advancing Efforts to Combat Systemic Medicare Waste, Which Aligns With Initiatives of the Newly-Formed Department of Government Efficiency (DOGE)
21 nov. 2024 23h43 HE
|
LifeWallet
LifeWallet Announces a $2 Million Pharmaceutical Litigation Settlement and Ongoing Settlement Negotiations with Multiple Pharmaceutical and P&C Insurers
EMPASSION ACHIEVES $34 MILLION IN SAVINGS IN NOVEL MEDICARE PROGRAM SERVING HIGH NEEDS PATIENTS
21 nov. 2024 09h27 HE
|
EmpassionHealth
NEW YORK CITY, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Empassion Health, Inc., the nation’s largest managed care provider of high-quality end-of-life care for adults living with serious illness so that...
LifeWallet Announces Third Quarter 2024 Financial Results
14 nov. 2024 16h24 HE
|
LifeWallet
LifeWallet Announces Third Quarter 2024 Financial Results
LifeWallet Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
12 nov. 2024 12h00 HE
|
LifeWallet
LifeWallet Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
Bloom Healthcare Achieves Industry-Leading Results in ACO REACH Model for 2023
12 nov. 2024 11h37 HE
|
Bloom Healthcare
For the second year in a row, Bloom Healthcare was a top performer in the ACO REACH model, improving care for high-needs patients.
LifeWallet Announces New Comprehensive Settlements Totaling More Than $5.9 Million, Continued Progress in Recoveries on Owned Claims and Acquiring Rights to Additional Claims, and Initiatives to Eliminate Wasteful Medicare Spending by Launching Beta Testing of Its Clearinghouse Solution, Built in Partnership with Palantir Technologies, Inc.
11 nov. 2024 22h21 HE
|
LifeWallet
LIFEWALLET ANNOUNCES NEW COMPREHENSIVE SETTLEMENTS TOTALING MORE THAN $5.9 MILLION, AND INITIATIVES TO ELIMINATE WASTEFUL MEDICARE SPENDING
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma
07 nov. 2024 07h30 HE
|
Adaptive Biotechnologies
clonoSEQ is the first and only assay to receive Medicare coverage for MRD assessment in MCL Coverage leverages new Medicare episode pricing established based on updated clonoSEQ gapfill rate ...
Privia Health Reports Third Quarter 2024 Financial Results
07 nov. 2024 06h00 HE
|
Privia Health Group, Inc.
Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to At or Above the High End for All MetricsAnnounced New Market Entry in Indiana Achieved MSSP 2023 Shared...
Recor Medical announces CMS Grant of Transitional Pass-Through (TPT) Payment for Recor’s Paradise Ultrasound Renal Denervation System for the Treatment of Uncontrolled Hypertension
01 nov. 2024 18h51 HE
|
Recor Medical
Palo Alto, CA, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced U.S. Centers for...
Allsup Employment Services Highlights Federal Benefit During National Disability Employment Awareness Month
30 oct. 2024 12h21 HE
|
Allsup
Belleville, Illinois, Oct. 30, 2024 (GLOBE NEWSWIRE) -- During National Disability Employment Awareness Month (NDEAM), Allsup Employment Services (AES) is shining a spotlight on the often-overlooked...